PARIS (Reuters) - Sanofi-Aventis has not changed its offer of $69 per share for drugmaker Genzyme, a Sanofi spokesman said Monday, declining to comment on a report that the drugmaker had lined up more financing for its bid.
PARIS (Reuters) - Sanofi-Aventis has not changed its offer of $69 per share for drugmaker Genzyme, a Sanofi spokesman said Monday, declining to comment on a report that the drugmaker had lined up more financing for its bid.
